Literature DB >> 22821427

Transient hemiparesis in a 14-year-old boy with MYH9 disorders.

Katsumasa Kitamura1, Shinji Kunishima, Mayu Tahara, Shigetoshi Ogiwara, Nana Dobata, Tomoyuki Dobata, Akemi Sugihara, Taiji Nakashima, Yasushi Sasaki, Kiyoshi Nagumo, Mitsuru Kubota, Yoshikazu Kinugawa, Masahiro Ieko, Satoru Kumaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22821427     DOI： 10.1007/s12185-012-1149-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  10 in total

1.  A large family with MYH9 disorder caused by E1841K mutation suffering from serious kidney and hearing impairment and cataracts.

Authors:  Jihong Hao; Shinji Kunishima; Xin Guo; Rui Hu; Weiguo Gao
Journal:  Ann Hematol       Date:  2011-11-15       Impact factor: 3.673

2.  Intriguing outcome of JAK2V617F mutation seen in a patient with MYH9-related hereditary macrothrombocytopenia.

Authors:  Fabrizio Fabris; Raffaella Scandellari; Silvia Vettore; Margherita Scapin; Nicola Bizzaro; Maria L Randi
Journal:  Thromb Haemost       Date:  2010-08-05       Impact factor: 5.249

3.  Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations.

Authors:  Alessandro Pecci; Paolo Gresele; Catherine Klersy; Anna Savoia; Patrizia Noris; Tiziana Fierro; Valeria Bozzi; Anna Maria Mezzasoma; Federica Melazzini; Carlo L Balduini
Journal:  Blood       Date:  2010-09-15       Impact factor: 22.113

4.  Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes).

Authors:  Antonio Girolami; Girolami Antonio; Silvia Vettore; Vettore Silvia; Emanuela Bonamigo; Bonamigo Emanuela; Fabrizio Fabris; Fabris Fabrizio
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

Review 5.  Advances in the understanding of MYH9 disorders.

Authors:  Shinji Kunishima; Hidehiko Saito
Journal:  Curr Opin Hematol       Date:  2010-09       Impact factor: 3.284

6.  Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations.

Authors:  Shinji Kunishima; Tadashi Matsushita; Tetsuhito Kojima; Masahiro Sako; Fumihiro Kimura; Eun-Kyeong Jo; Chikako Inoue; Tadashi Kamiya; Hidehiko Saito
Journal:  Lab Invest       Date:  2003-01       Impact factor: 5.662

7.  Coronary thrombosis in a patient with May-Hegglin anomaly.

Authors:  S McDunn; W Hartz; C Ts'Ao; D Green
Journal:  Am J Clin Pathol       Date:  1991-05       Impact factor: 2.493

8.  Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome).

Authors:  Kathleen Selleng; Lena E Lubenow; Andreas Greinacher; Theodore E Warkentin
Journal:  Eur J Haematol       Date:  2007-07-26       Impact factor: 2.997

9.  Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.

Authors:  Alessandro Pecci; Emanuele Panza; Núria Pujol-Moix; Catherine Klersy; Filomena Di Bari; Valeria Bozzi; Paolo Gresele; Stefan Lethagen; Fabrizio Fabris; Carlo Dufour; Antonio Granata; Michael Doubek; Carmine Pecoraro; Pasi A Koivisto; Paula G Heller; Achille Iolascon; Patrizia Alvisi; Dirk Schwabe; Erica De Candia; Bianca Rocca; Umberto Russo; Ugo Ramenghi; Patrizia Noris; Marco Seri; Carlo L Balduini; Anna Savoia
Journal:  Hum Mutat       Date:  2008-03       Impact factor: 4.878

10.  Unexplained recurrent venous thrombosis in a patient with MYH9-related disease.

Authors:  Paula G Heller; Alessandro Pecci; Ana C Glembotsky; Anna Savoia; Fernando D Negro; Carlo L Balduini; Felisa C Molinas
Journal:  Platelets       Date:  2006-06       Impact factor: 3.862
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.